01521.HK
Frontage Holdings Corporation
HKSE · Healthcare · Biotechnology · US
HKD 1.30
−0.38%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 28.32x
- P/E 2027E
- 14.14x
- P/E 2028E
- 16.40x
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- 23.59x
- PEG TTM
- —
- Price / book
- 0.94x
- Price / sales
- 0.63x
- Price / cash flow
- 7.62x
Enterprise value
- Enterprise value
- HKD 3.5B
- EV / sales
- 0.83x
- EV / EBITDA
- 4.78x
- EV / EBIT
- 12.87x
- Market cap
- HKD 2.6B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026